Cancer
Glutamine Joins Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Cancer Trial
The phase 1 GlutaPanc trial shows that l-glutamine can be safely combined with first-line gemcitabine and nab-paclitaxel in advanced pancreatic...
Cancer Drug Lapatinib Offers Safer HER2 Route for Patients With Failing Hearts
A new clinical case report shows that the oral HER2 inhibitor lapatinib, with its short half-life and low cardiac toxicity,...
Thyroid Cancer Protein Rewires Tumor Metabolism and Drives Drug Resistance
New research shows the protein ECT2 drives papillary thyroid carcinoma growth by suppressing lipoic acid metabolism, activating PI3K/AKT signaling and...
Gene Mutations After Surgery Predict Lung Cancer Recurrence Risk in Large Chinese Cohort
A retrospective cohort study of 1,674 Chinese lung cancer patients identifies TP53 and TP53-MET co-mutations as independent predictors of poorer...
RNA Profiling Splits Deadly Dog Spleen Cancer into Three Actionable Subtypes
Researchers at the University of São Paulo used a qPCR-based gene expression panel to divide canine splenic hemangiosarcoma into three...
Breast Cancer Is Striking Later in Life—But Only for the Rich, 47-Year Study Finds
A 46-year SEER analysis of nearly 700,000 breast cancer patients shows the rise in age at diagnosis is concentrated among...
How Well You Walk at Hospital Discharge May Predict Glioblastoma Survival
A retrospective study of 185 glioblastoma patients finds that walking ability measured at hospital discharge independently predicts overall survival beyond...
Machine Sorting of Cancer Distress: Data Profiles Could Reshape Psycho-Oncology Triage in Head and Neck Cancer
Researchers in Zurich used machine learning cluster analysis of five biopsychosocial domains to identify three distinct patient profiles within a...
Muscle Weakness Before Cancer Diagnosis: Rare Case Links Myopathy to Burkitt Lymphoma
A rare case report describes an immunocompetent adult whose progressive muscle weakness and elevated CPK turned out to be a...
Perioperative Immunotherapy More Than Doubles Event-Free Survival in Early-Stage Lung Cancer
Final Phase 3 IMpower030 results show that perioperative atezolizumab plus chemotherapy extended median event-free survival to 62.8 months versus 34.9...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!